Steven Baertschi is president of Baertschi Consulting, a firm specializing in solutions to the most difficult pharmaceutical stability, impurity, analytical, solid-state, and formulation issues. He retired from Eli Lilly and Company in 2015, after more than 29 years of experience in the pharmaceutical industry. He obtained his PhD in organic chemistry in 1989 from Vanderbilt […]
Biography
Steven Baertschi is president of Baertschi Consulting, a firm specializing in solutions to the most difficult pharmaceutical stability, impurity, analytical, solid-state, and formulation issues. He retired from Eli Lilly and Company in 2015, after more than 29 years of experience in the pharmaceutical industry. He obtained his PhD in organic chemistry in 1989 from Vanderbilt University.
Biography
Steven Baertschi is president of Baertschi Consulting, a firm specializing in solutions to the most difficult pharmaceutical stability, impurity, analytical, solid-state, and formulation issues. He retired from Eli Lilly and Company in 2015, after more than 29 years of experience in the pharmaceutical industry. He obtained his PhD in organic chemistry in 1989 from Vanderbilt University.